Psychedelic Support Company Profile

Background

Overview

Psychedelic Support is a leading organization dedicated to advancing the safe and therapeutic use of psychedelics. Established in 2018, the organization offers a comprehensive platform that connects individuals with licensed healthcare providers, community groups, and educational resources focused on psychedelic-assisted therapies. Their mission is to accelerate personal and global transformation by advancing legal psychedelic-assisted therapies.

Mission and Vision

The mission of Psychedelic Support is to serve as a premier organization of continuing education, dedicated to advancing the knowledge, skills, and practice of healthcare professionals worldwide. Through innovative and evidence-based educational programs, they empower practitioners with the latest advancements in psychedelic medicine to deliver exceptional care with the highest degree of safety to individuals seeking healing and personal growth.

Primary Area of Focus

Psychedelic Support focuses on providing education, resources, and connections for the safe and therapeutic use of psychedelics. Their services include a directory of licensed health providers, community groups, and educational programs related to psychedelic-assisted therapies.

Industry Significance

As the field of psychedelic-assisted therapy gains recognition for its potential in treating mental health conditions, Psychedelic Support plays a pivotal role in bridging the gap between emerging therapeutic practices and the broader healthcare community. By offering a centralized platform for education and professional networking, they contribute significantly to the integration of psychedelics into mainstream mental health care.

Key Strategic Focus

Core Objectives

Education and Training: Develop and provide accredited educational programs to healthcare professionals, enhancing their understanding and application of psychedelic-assisted therapies.

Professional Networking: Facilitate connections among healthcare providers through platforms like Professional Connect, enabling collaboration and knowledge sharing.

Community Engagement: Support and connect individuals with community groups that focus on integration, harm reduction, and personal growth related to psychedelic experiences.

Specific Areas of Specialization

Psychedelic-Assisted Therapies: Focus on the therapeutic use of substances such as MDMA, psilocybin, and ketamine in treating mental health conditions.

Professional Education: Offer continuing education courses and certifications for healthcare providers in the field of psychedelic medicine.

Community Support: Provide resources and connections to community groups that offer support for individuals undergoing psychedelic-assisted therapies.

Key Technologies Utilized

Online Educational Platforms: Utilize digital platforms to deliver courses, webinars, and training programs to a global audience.

Professional Networking Tools: Develop and maintain platforms like Professional Connect to facilitate networking and collaboration among healthcare providers.

Primary Markets or Conditions Targeted

Mental Health Disorders: Address conditions such as depression, anxiety, PTSD, and substance use disorders through psychedelic-assisted therapies.

Healthcare Professionals: Target medical doctors, therapists, counselors, and other healthcare providers seeking education and resources in psychedelic medicine.

Financials and Funding

Specific details regarding Psychedelic Support's funding history, total funds raised, recent funding rounds, and notable investors are not publicly disclosed. The organization operates as a not-for-profit entity, focusing on reinvesting resources into its educational programs, community initiatives, and professional networking services.

Pipeline Development

As a not-for-profit organization, Psychedelic Support does not engage in the development of pharmaceutical products or clinical trials. Instead, their focus is on providing educational resources, professional networking opportunities, and community support related to psychedelic-assisted therapies.

Technological Platform and Innovation

Proprietary Technologies

Professional Connect: A networking platform designed to connect healthcare providers specializing in psychedelic-assisted therapies, facilitating collaboration and knowledge sharing.

Significant Scientific Methods

Accredited Educational Programs: Offer evidence-based courses and training programs to healthcare professionals, enhancing their understanding and application of psychedelic-assisted therapies.

Leadership Team

Allison Feduccia, PhD – Co-Founder and CEO

Dr. Feduccia is a neuropharmacologist, psychedelic researcher, and educator. She co-founded Psychedelic Support in 2018 and has been instrumental in developing its educational programs and professional networking platforms. Dr. Feduccia began researching MDMA in 2004 and has worked on mental health research at institutions such as UT Austin, UCSF, NIH, and MAPS PBC. She has authored over 30 publications on psychedelics and mental health in peer-reviewed journals.

Dafna Bornstein – Psychotherapist

Ms. Bornstein is a licensed psychotherapist specializing in psychedelic integration therapy. She contributes to Psychedelic Support by providing therapeutic services and educational content related to psychedelic-assisted therapies.

Saskia Brinkerhoff – Education and Outreach Coordinator

Ms. Brinkerhoff coordinates educational programs and outreach initiatives, aiming to expand the reach of Psychedelic Support's resources and connect with a broader audience.

Nina van den Berg – Communications Coordinator

Ms. van den Berg manages communications and marketing efforts, ensuring that Psychedelic Support's message reaches healthcare professionals and the general public effectively.

Market Insights and Competitor Profile

The psychedelic-assisted therapy market is experiencing significant growth, driven by increasing recognition of the therapeutic potential of substances like psilocybin, MDMA, and ketamine. This growth is accompanied by a surge in research, investment, and the development of related services, including education, professional networking, and community support.

Key Competitors

Mindbloom: A telemedicine company offering ketamine-assisted therapy for mental health conditions. Mindbloom provides at-home treatment options and has contributed to studies researching the effectiveness of ketamine as a treatment for mental health-related issues.

Psychedelic.help: A platform connecting individuals with qualified professionals specializing in psychedelic integration therapy. They offer a directory of verified integration specialists and facilitate connections for personalized support.

Evolute Institute: A private organization based in the Netherlands offering programs combining legal psychedelic retreats with professional coaching and integration practices. Their programs are aimed at personal and leadership development, primarily attracting entrepreneurs and executives.

Strategic Collaborations and Partnerships

Psychedelic Support has collaborated with various organizations to enhance its offerings, including partnerships with educational institutions and community groups. These collaborations aim to expand access to psychedelic-assisted therapies and support the integration of these practices into mainstream healthcare.

Operational Insights

Psychedelic Support differentiates itself by focusing on education, professional networking, and community support, rather than direct therapeutic services. This approach allows them to serve as a comprehensive resource for individuals and healthcare providers interested in psychedelic-assisted therapies.

Strategic Opportunities and Future Directions

Psychedelic Support plans to expand its educational programs, enhance its professional networking platforms, and strengthen community engagement initiatives. By leveraging its expertise and resources, the organization aims to play a pivotal role in the integration of psychedelic-assisted therapies into mainstream mental health care.